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ABSTRACT  
Objective: The present study was designed to investigate an anxiolytic effect of chloroform and ethanol extract of Sargassum ilicifolium (SI) and 
Padina tetrastomatica (PT) in mice. 
Methods: Acute toxicity study was done as per OECD 423 guidelines. Based on acute toxicity studies, doses of 200, 400 and 600 mg/kg of SI and PT 
extracts were selected, and the anxiolytic activity was assessed using Elevated plus maze (EPM) and light/dark exploration (L/DE) tests.  
Results: Diazepam (2 mg/kg), the ethanol extract of SI (400 mg/kg) as well as ethanol extract of PT (600 mg/kg) significantly increased time spent 
and entries into the open arm in EPM test. In L/DE test Diazepam, chloroform extract (600 mg/kg) and ethanol extract (400 mg/kg) of SI as well as 
chloroform extract (600 mg/kg) and ethanol extract (600 mg/kg) of PT significantly increased time spent in light box and transition between the 
boxes.  
Conclusion: in the present investigation, ethanol extract at 400 and chloroform extract at 600 mg/kg of Sargassum ilicifolium as well as ethanol 
extract at 400 and 600 mg/kg and chloroform extract at 600 mg/kg of Padina tetrastomatica exhibited an anxiolytic effect in the experimental 
model of anxiety. However, additional research will be necessary to investigate the mechanism underlying this anxiolytic activity.  
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INTRODUCTION 
Anxiety, an emotional state is one of the most frequently occurring 
psychiatric disorder [1]. This is increasingly recognized as a highly 
prevalent and chronic disorder with incidences of 18.1 % and 
prevalence of 28.8% [2]. Despite a steady increase in the 
development of anxiolytic agents, the prevalence of the disorder 
remains stable that could be attributed to the unknown 
neurobiological understanding of pathophysiology or the 
inconsistent efficacy of current pharmacological treatment. Selective 
Serotonin Reuptake Inhibitors (SSRIs) are the commonly prescribed 
drugs for the treatment of depression and several anxiety disorders. 
Unfortunately, the onset of action of SSRIs is often delayed by 3–6 w. 
The existence of this delayed action combined with the fact that one-
third of patients do not respond to treatment [3]. Benzodiazepine 
class agents have widespread therapeutic potentials and are 
generally prescribed medication for the treatment of several forms 
of anxiety, but these agents have prominent side effects, such as 
sedation, dependence, cognitive and psychomotor impairment [4, 5]. 
These are some of the factors that cause interest for many 
researchers to evaluate new compounds from a natural source with 
fewer unwanted side effects. Many traditional herbs and herbal 
medicines have been reported as anxiolytic agents. However, the 
marine flora has not explored up to that extent for their CNS activity. 
Hence, we undertook the study to evaluate CNS potential of some 
marine macroalgae. 
Marine macroalgae or seaweeds are found in the coastal region 
between high tide to low tide and in the subtidal region up to a 
depth where 0.01 % photosynthetic light is available. Marine 
macroalgae have created a promising significance in the biomedical 
area, mainly because of their contents of bioactive substances. 
Polysaccharides, terpenoids, phlorotanins, fucoidans, sterols, and 
glycolipids show wide range of pharmacological properties which 
includes anticancer, anti-inflammatory, antimicrobial, antiviral, 
antioxidant, hypoglycemic, hepatoprotective and neuroprotective 
activities [6, 7]. Also, some marine organism and marine macroalgae 
showed the potential as a source of new drugs for the treatment of 
neurological disorders [8, 9]. Due to natural constituent and 
availability, marine flora are believed to provide less untoward 
effect profiles and provide greater effectiveness as compared to the 
synthetic drug. 
Sargassum ilicifolium (Turner) C. Agardh is tropical and sub-tropical 
brown algae, distributed in the open intertidal coast of Gujarat, 
Maharashtra, Goa, Karnataka and Lakshadweep. Ethyl acetate 
extract of Sargassum ilicifolium has been reported to possess 
immunomodulatory activities [10], alcoholic extract of this seaweed 
reported for antibacterial activity [11], analgesic and anti-
inflammatory activity [12] and antioxidant and anticancer activity 
[13]. Furthermore, the antidepressant-like activity of Sargassum 
ilicifolium had been previously reported in mice models of 
depression [14].  
Padina tetrastomatica (Hauck) is a marine brown alga found in the 
coastal areas of India. Methanolic extract of Padina tetrastromatica 
have reported for spasmogenic, anti-fertility, hypotensive properties 
[15] and in vitro antioxidant activity [16, 17]. Sulphated 
polysaccharide from Padina tetrastromatica showed significant anti-
inflammatory activity against carrageenan induced paw edema [18]. 
Also, it reported to possess anti hepatitis B virus activity [19]. 
Furthermore, chloroform, ethanol, and water extract of Padina 
tetrastromatica showed antimicrobial activity against gram positive, 
gram negative bacterial and fungal test [20].  
However, the anxiolytic effect of Sargassum ilicifolium and Padina 
tetrastomatica has not been investigated. Hence, we evaluated the 
anxiolytic activity of Sargassum ilicifolium and Padina tetrastomatica 
using experimental models as Elevated Plus Maze (EPM) test and 
Light/Dark Exploration (L/DE) Test. 
MATERIALS AND METHODS 
Animals  
Swiss albino mice (25-30 g) were used for the experiment purpose. 
The animals were housed in solid-bottomed polypropylene cages 
and acclimatized to animal house conditions (temperature 25±2 °C, 
12 h light: 12 h dark cycle and relative humidity 50±5%). The mice 
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were fed with commercial standard diet and water ad libitum. The 
experiments were designed and conducted in accordance with the 
guideline of CPCSEA and approved by Institutional Animal Ethical 
Committee (Approval No. GNCP/IAEC/2011-12/P’cology-01). 
Drugs and chemicals  
Diazepam (Calmpose Inj. Ranbaxy, India) was purchased from a local 
vendor and used as reference drug. Chloroform (Hi Media 
Laboratories, Mumbai), Ethanol (Research Lab Fine Chem, Mumbai) 
were used for extraction of SI and PT. The drug was dissolved in 
distilled water and all extracts were suspended in 5 % Tween 80. 
Seaweed collection and extracts preparation  
The brown seaweeds, Sargassum ilicifolium (SI) and Padina 
tetrastomatica (PT) were collected from the inter-tidal rocky shore 
of Bhatkarwada, Ratnagiri coast in Nov-Dec 2011. The seaweed 
species was identified by Professor B. B. Chaughule, Emeritus 
Professor, Department of Botany, University of Pune, Pune (India). 
The fresh sample was washed with sea water followed by fresh 
water to remove salts, epiphytes, microorganisms and other 
suspended materials, and dried at room temperature. The air-dried 
and coarsely powdered sample was extracted successively using 
Soxhlet apparatus by Petroleum Ether, Chloroform, and Ethanol. 
Phytochemical analysis  
The Chloroform and ethanol extracts of SI and PT were analyzed for 
the presence of phytochemicals by qualitative analysis [21, 22]. 
Acute toxicity studies  
The Acute toxicity was determined on Swiss albino mice as per 
OECD-423 guidelines [23]. The overnight fasted animals were 
administered extracts orally at the dose level of 2000 mg/kg body 
weight and were continuously observed for 2 h to detect changes in 
the autonomic or behavioural responses and then, monitored for any 
mortality for the following 7 d. 
Experimental setup  
The animals were randomly assigned to experimental groups (6 
mice per group) as follows (table 1): 
Elevated plus maze (EPM) test  
Elevated plus maze is the simplest apparatus to study the anxiolytic 
response of almost all types of anti-anxiety agents. Modified method 
as described earlier by Lister (1987) was used in this study [24]. The 
maze consisted of two opposite open (30 cm×7 cm×0.5 cm) and two 
opposite closed (30 cm×7 cm×15 cm) arms, extending from a central 
platform (7 cm ×7 cm) and elevated to a height of 45 cm above the 
floor. Mice were individually placed on the center of the maze facing 
an open arm, and the number of entries and the time spent in the 
closed and open arms were recorded during a 5 min observation 
period. Arm entries were defined as the placement of all four paws 
into an arm [25]. 
Light/dark exploration (L/DE) test  
This test is based on the innate aversion of rodents to brightly lit 
areas and on their spontaneous exploratory behavior in response to 
a novel environment and to light [26]. The apparatus consisted of 
two boxes (25×25×25 cm) joined together. One box was made dark 
by covering its top with plywood and a 40 W lamp illuminated the 
other box.  
The light source was placed 25 cm above the open box. The mice 
were placed individually in the center of the light box and observed 
for the next 5 min for a number of crossing to light compartment and 
time spent in the light box [25]. 
 
Table 1: Grouping of animals and treatment 
Group Treatment Dose 
Vehicle Distilled water 1 ml/100 g, p. o. 
Diazepam  Diazepam 2 mg/kg, i. p 
CSI 200 Chloroform extract of Sargassum ilicifolium 200 mg/kg, p. o. 
CSI 400 Chloroform extract of Sargassum ilicifolium 400 mg/kg, p. o. 
CSI 600 Chloroform extract of Sargassum ilicifolium 600 mg/kg, p. o. 
ESI 200 Ethanol extract of Sargassum ilicifolium 200 mg/kg, p. o. 
ESI 400 Ethanol extract of Sargassum ilicifolium 400 mg/kg, p. o. 
ESI 600 Ethanol extract of Sargassum ilicifolium 600 mg/kg, p. o. 
CPT 200 Chloroform extract of Padina tetrastomatica 200 mg/kg, p. o. 
CPT 400 Chloroform extract of Padina tetrastomatica 400 mg/kg, p. o. 
CPT 600 Chloroform extract of Padina tetrastomatica 600 mg/kg, p. o. 
EPT 200 Ethanol extract of Padina tetrastomatica 200 mg/kg, p. o. 
EPT 400 Ethanol extract of Padina tetrastomatica 400 mg/kg, p. o. 
EPT 600 Ethanol extract of Padina tetrastomatica 600 mg/kg, p. o. 
All extracts were dissolved in 5 % Tween-80 while; diazepam was dissolved in distilled water. The extracts were administered orally for seven days 
and anxiolytic activity was carried out on last day of treatment. 
 
Locomotor activity 
The locomotor activity (horizontal activity) was measured using 
digital actophotometer (INCO, Ambala, India). Each mouse was 
placed in the actophotometer for 5 min and locomotor score was 
obtained [27].  
Statistical analysis  
Results were expressed as mean±SEM. The data was analyzed using 
one-way analysis of variance (ANOVA) followed by Dunnett’s test, 
and P<0.05 was considered as statistically significant. 
RESULTS 
Phytochemical analysis  
The qualitative phytochemical analysis revealed the presence of 
sterols, terpenoids, flavonoids, alkaloids, glycosides and saponin in 
chloroform and ethanol extract of SI and PT (table 2). 
Acute toxicity studies  
Since no mortality was observed at 2000 mg/kg as well as at 5000 
mg/kg. Therefore, doses of 200, 400 and 600 mg/kg of SI and PT 
extracts were selected for further study. 
Elevated plus maze test  
In EPM test, ethanol extract of SI (400 mg/kg) and diazepam exhibit 
significant (p<0.01) increased in time spent in the open arm, 
whereas there was significant (p<0.05) decreased in time spent and 
number of entries in the close arm, compared to the vehicle treated 
group. While, CSI (200, 400, 600 mg/kg) and ESI (200, 600 mg/kg) 
did not produce a significant effect on behaviour of mice in EPM (fig. 
1). Also ethanol extract of PT (600 mg/kg) and diazepam 
significantly (p<0.01) increased time spent in open arm, EPT (400 
and 600 mg/kg) significantly (p<0.05) increased number of entries 
in open arm and EPT (600 mg/kg) significantly (p<0.01) decreased 
time spent in the open arm compared with vehicle-treated group. 
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While CPT (200, 400, 600 mg/kg) and EPT (200, 400 mg/kg) 
showed no significant change on EPM test (fig. 2). 
Light/dark exploration test  
In Light/Dark exploration test, diazepam significantly (p<0.01) 
increased the time spent in the light box as well as the number of 
crossing between light and dark boxes. The treatment with CSI (600 
mg/kg) and ESI (400 mg/kg) significantly (p<0.05) increased the 
time spent in the light box, while ESI (400 mg/kg) significantly 
(p<0.05) increased number of crossing between light and dark 
boxes. However, no significant difference was observed on this 
parameter at CSI (200, 400 mg/kg) and ESI (200, 600 mg/kg) as 
compared to the vehicle-treated group (fig. 3).  
Furthermore, the treatment with diazepam, CPT (600 mg/kg) and 
EPT (600 mg/kg) showed significant (p<0.05) increase in the time 
spent in the light box. While diazepam, CPT (600 mg/kg) showed 
significantly (p<0.01) increased number of crossing between light 
and dark boxes. Whereas, CPT (200, 400 mg/kg) and EPT (200, 400 
mg/kg) did not produce significant change on the Light/Dark 
exploration test as compared with vehicle-treated group (fig. 4). 
 
Table 2: Qualitative phytochemical analysis of extracts of Sargassum ilicifolium and Padina tetrastomatica 
Plant constituents CSI ESI CPT EPT 
Tests for Tannins - - - - 
Test for Steroids + + + + 
Test for terpenoid + + + - 
Tests for Flavonoids + + + - 
Tests for Alkaloids + + + + 
Tests for Carbohydrates  + + + + 
Test for Glycosides + + - + 




Fig. 1: Effect of Sargassum ilicifolium on (A) time spent(s) in open arm, (B) time spent(s) in closed arm, (C) entries in open arm and (D) 
entries in closed arm in elevated plus maze test 
(n=6); * p<0.05, ** p<0.01, significantly differ from vehicle 
 
 
Fig. 2: Effect of Padina tetrastomatica on (A) time spent(s) in open arm, (B) time spent(s) in closed arm, (C) entries in open arm and (D) 
entries in closed arm in elevated plus maze test 
(n=6); * p<0.05, ** p<0.01, significantly differ from vehicle 
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Fig. 3: Effect of Sargassum ilicifolium on time spent in light box and number of crossing in Light/Dark exploration test 
(n=6); * p<0.05, ** p<0.01, significantly differ from vehicle 
 
 
Fig. 4: Effect of Padina tetrastomatica on time spent in light box and number of crossing in Light/Dark exploration test 
(n=6); * p<0.05, ** p<0.01, significantly differ from vehicle 
 
Locomotor activity  
Diazepam (p<0.01) and EPT (600 mg/kg) (p<0.05) significantly 
reduced locomotor score. However, other doses of chloroform and 
ethanol extract of SI and PT did not produce a significant difference 
in the locomotor score of mice, when compared with vehicle-treated 
group (fig. 5 and fig. 6). 
 
 
Fig. 5: Effect of sargassum ilicifolium on locomotor score in mice  
(n=6); ** p<0.01, significantly differ from vehicle 
 
 
Fig. 6: Effect of Padina tetrastomatica on locomotor score in mice  
(n=6); * p<0.05, ** p<0.01, significantly differ from vehicle 
DISCUSSION  
The EPM test is a most popular and valid animal model for 
measuring anxiety by investigating aspects of physiological and 
pharmacological behaviour [28, 29]. This test has been widely used 
to screen anxiolytic or anxiogenic effects because of its use of natural 
conditions and stimuli to induce anxiety, such as a fear of a new, 
bright, and open space and the fear of balancing on a relatively 
narrow raised surface [30, 31]. In this study, the ethanol extract of SI 
(400 mg/kg) as well as ethanol extract of PT (600 mg/kg) 
significantly increased time spent and entries into the open arm of 
EPM, similar to those of diazepam.  
The anxiolytic-like activity was also observed in light/dark 
exploration test. L/DE test is widely used with rodents as a model 
for screening anxiolytic and anxiogenic drugs, based on the innate 
aversion of rodents to bright areas and on the spontaneous 
exploratory behaviours of rodents in response to novel 
environments and light [26, 32]. In the present study, it was 
observed that chloroform extract (600 mg/kg) and ethanol extract 
(400 mg/kg) of SI as well as chloroform extract (600 mg/kg) and 
ethanol extract (600 mg/kg) of PT significantly increased time spent 
in light box and transition between the boxes of L/DE test. Diazepam 
also causes an increase in time spent and latency time to leave the 
light box in L/DE test. 
The locomotor effect of extracts of SI, PT and diazepam, were tested 
in the present study. However, none of the doses except EPT (600 
mg/kg) and diazepam affected spontaneous locomotor activity. 
Which indicated that ESI (400 mg/kg), CSI (600 mg/kg) and EPT 
(600 mg/kg) induced anxiolytic effect with an absence of sedative 
action. 
Furthermore, considerable research has been shown that the 
anxiolytic-like effects of diazepam are mediated through an 
activation of brain neurotransmitter γ-amino-butyric acid (GABA) at 
the GABA receptor complex [33]. In another study, we have reported 
antidepressant-like activity of Sargassum ilicifolium in Forced Swim 
test and Tail Suspension test in mice [14]. The antidepressant-like 
activity of Sargassum ilicifolium was believed to be mediated 
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through noradrenergic or serotonergic mechanism. Also, Zhang et al. 
(2004) reported that monoaminergic system [serotonin (5HT) and 
norepinephrine (NA)] in a brain has been postulated to plays an 
important role in the pathophysiology of anxiety disorders [34]. 
Which supported by several preclinical and clinical reports 
indicating dysfunction of the monoaminergic system may be 
implicated as a promising mechanism in the pathophysiology of 
anxiety disorders [35-37]. In this regard, anxiolytic-like effects of SI 
and PT in the present study might be dependent on modulation of 
GABA and/or monoaminergic (NA and 5HT) system. Further 
investigations are required to clarify the detailed anxiolytic 
mechanism. 
CONCLUSION  
From the results, it can be concluded that chloroform and ethanolic 
extract of Sargassum ilicifolium and Padina tetrastomatica at a dose 
of 400 and 600 mg/kg respectively possess anxiolytic activity in 
EPM and LDE test, possibly due to the presence of different 
phytochemicals like alkaloids, steroids, terpenoids, flavonoids 
present therein. However, further research will be necessary to 
investigate the mechanism underlying this anxiolytic activity. 
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